A recent study led by a team of researchers at The Johns Hopkins University School of Medicine examining aging mice has provided what is believed to be the first evidence that amyloid beta ...

Clumps or plaques of the protein beta-amyloid in the brain are a hallmark of a type of dementia called Alzheimer’s disease. When beta-amyloid plaques form, they disrupt communication between nerve ...

A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...

A research group has investigated how Alzheimer's disease can be diagnosed more reliably in the future. A research group at LMU University Hospital has investigated how Alzheimer's disease can be ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive neurodegenerative disease that is characterized by cognitive decline. Given ...

Getting your steps in could help fight off Alzheimer's, new research has found. Regular aerobic exercise was linked to a reduction in markers in the brains of in rats that associated with the onset of ...

In Alzheimer's disease, proteins like amyloid beta form clumps, known as plaques, that damage the brain. But in some people, immune cells called microglia break down these proteins before they can ...

Piller is an investigative journalist for Science. In November 2022, Dennis Selkoe, a Harvard professor of neurologic diseases and among the most celebrated and prolific Alzheimer’s researchers, ...

(TNND) — A study at the University of Virginia might offer hope to Alzheimer's patients in the future. Researchers found that blocking a brain-defense molecule in mice prevented memory loss and other ...

Selkoe is co-director of the Ann Romney Center for Neurologic Diseases, Department of Neurology, Mass General Brigham, and Vincent and Stella Coates professor of neurologic diseases at Harvard Medical ...

This article originally appeared on Undark. For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive neurodegenerative disease that is ...